1      0

National Symposium 2014

221 - Hypertension in Hemodialysis

Apr 15, 2014 1:30pm ‐ Apr 15, 2014 2:45pm

Standard: $20.00
Members: $0.00


Contact hours available until 4/16/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Speaker, Faculty, Planners and Authors Conflict of Interest Disclosure:
Speaker(s) have no disclosures to declare.

Planning Committee:
• Annette Hood discloses that she is a member of the Amgen speakers’ bureau.
• Denise Murcek discloses other financial/material support as an employee of the VA Medical Center.
• Elizabeth St. John discloses other financial/material support as an employee of Fresenius Medical Care.
• Kyra Trappett discloses other financial/material support as an employee of DaVita.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

• Review the prevalence of hypertension in hemodialysis and the associated risks of uncontrolled hypertension.
• Discuss the underlying causes of hypertension in hemodialysis.
• Identify blood pressure goals for hemodialysis patients.
• Review the blood pressure medication classes used to treat hypertension in hemodialysis.
• Discuss major side effects and interactions associated with each drug class.


You must be logged in and own this session in order to post comments.